About vivani medical inc - VANI
Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.
VANI At a Glance
Vivani Medical, Inc.
1350 South Loop Road
Alameda, California 94502
| Phone | 1-415-506-8462 | Revenue | 0.00 | |
| Industry | Medical Specialties | Net Income | -26,609,000.00 | |
| Sector | Health Technology | Employees | 42 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
VANI Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 5.976 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -2.934 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.24 |
VANI Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -633,547.619 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
VANI Liquidity
| Current Ratio | 2.711 |
| Quick Ratio | 2.711 |
| Cash Ratio | 2.459 |
VANI Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -64.046 |
| Return on Equity | -159.622 |
| Return on Total Capital | -76.388 |
| Return on Invested Capital | -77.843 |
VANI Capital Structure
| Total Debt to Total Equity | 121.449 |
| Total Debt to Total Capital | 54.843 |
| Total Debt to Total Assets | 45.997 |
| Long-Term Debt to Equity | 108.462 |
| Long-Term Debt to Total Capital | 48.978 |